Irmandade da Santa Casa de Misericordia de Sao Paulo

São Paulo 01223-001

1 studies enrolling now · 6 studies all time

What they study most

Acute Coronary Syndrome, Autologous Stem Cell Transplant, Multiple Myeloma, Multiple Sclerosis, Relapsing-Remitting, Non-Muscle Invasive Bladder Neoplasms, Proteinuric Kidney Disease, Relapsed or Refractory Systemic Light Chain Amyloidosis

Studies at this site

• Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease — Recruiting now
• A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer — Recruiting now
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis — Stopped early
• A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant — Completed
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two — Completed